Facebook
Twitter
LinkedIn
Forward
19th Annual International Ultmann Chicago Lymphoma Symposium
We are fortunate to have a multitude of the world’s experts in lymphoma speak each year at the conference. The audience is comprised of regional practicing oncologists, advanced nurse practitioners and physician assistants, residents, fellows, and the Chicago academic community that includes five academic centers.
This is a certified continuing medical education (CME) activity that focuses on the biologic, diagnostic, and therapeutic aspects of Hodgkin lymphoma and non-Hodgkin lymphoma. This year’s meeting will be a 2-day live meeting to discuss recent updates in the care of patients with solid and hematologic malignancies. A virtual live stream option will also be available for participants unable to travel.
Target Audience
Learning Objectives
At the conclusion of this educational activity, participants will be able to:
- Compare and contrast the latest approaches to the treatment of patients with indolent and aggressive forms of non-Hodgkin lymphoma;
- Evaluate current and emerging approaches to the treatment of patients with Hodgkin lymphoma;
- Assess the latest clinical trial data of current and emerging CAR T-cells and cellular therapy for patients with hematologic malignancies, including important safety and efficacy data;
- Discuss patient and disease-related factors that impact the selection and sequencing of therapy for patients with CLL;
- Develop strategies to utilize the entire multidisciplinary team during the continuum of care of patients with lymphoma.
HYBRID CONFERENCE
WANT TO KNOW MORE?
ACCESSIBILITY The University of Chicago is committed to providing equal access appropriate to need and circumstances and complies fully with legal requirements of the Americans with Disabilities Act. If you are in need of special accommodation, please contact our office via e-mail at iucls@bioascend.com.
The University of Chicago reserves the right to cancel or postpone this conference due to unforeseen circumstances. In the unlikely event this activity must be cancelled or postponed, the registration fee will be refunded; however, The University of Chicago is not responsible for any related costs, charges, or expenses to participants, including fees assessed by airline/travel/lodging agencies.
SYMPOSIUM CO-CHAIRS
Sonali M. Smith, MDElwood V. Jensen Professor of Medicine
Chief, Section of Hematology/Oncology
Director, Lymphoma Program
The University of Chicago
Andrew M. Evens, DO, MScProfessor of Medicine, Rutgers Robert Wood Johnson Medical School
Associate Director for Clinical Services, Rutger Cancer Institute of New Jersey
Medical Director, Oncology Service Line, RWJBarnabas Health
Milwaukee, Wisconsin
Disclosure Declarations
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone in a position to control the content of an education activity to disclose all financial relationships with any ineligible companies. This includes any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if a financial relationship, in any amount, exists between the person in control of content and an ineligible company during the past 24 months, and the content of the education is related to the products of an ineligible company with whom the person has a financial relationship. Mechanisms are in place to identify and mitigate any relevant financial relationships prior to the start of the activity.
Additionally, The University of Chicago Pritzker School of Medicine requires Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration at first mention and where appropriate in the content.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Chicago Pritzker School of Medicine and Bio Ascend LLC. The University of Chicago Pritzker School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
The University of Chicago Pritzker School of Medicine designates this live activity for a maximum of 14.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Credit
This live activity is designated for a maximum of 14.5 continuing nursing education units.
Other Healthcare Professions Credit
Other healthcare professionals will receive a Certificate of Participation. For information on the applicability and acceptance of certificates of participation for educational activities certified for AMA PRA Category 1 Credits™ from organizations accredited by the ACCME, please consult your professional licensing board.
Please Note: Requests to claim MOC Part II credit must be made within one month to report to ABIM. Requests to claim AMA PRA Category 1 Credit™ after three months will be subject to additional fees.
REGISTRATION
Symposium and Nursing Session
| Access Type | Early Bird Fee | After Early Bird Fee | Virtual |
|---|---|---|---|
| Physicians | $325 | $375 | $125 |
| Nurse/OHP | $150 | $175 | $75 |
| Resident/Fellow | $125 | $150 | $50 |
| Industry | $600 | $750 | $200 |
| Access Type | Early Bird Fee | After Early Bird Fee | Virtual |
|---|---|---|---|
| Physicians | $275 | $325 | $50 |
| Nurse/OHP | $125 | $150 | $25 |
| Resident/Fellow | $100 | $125 | $25 |
| Industry | $450 | $150 | $125 |
| Access Type | Early Bird Fee | After Early Bird Fee | Virtual | |
|---|---|---|---|---|
| Physicians | $100 | $150 | $50 | |
| Nurse/OHP | $75 | $100 | $25 | |
| Resident/Fellow | $75 | $100 | $25 | |
| Industry | $150 | $200 | $125 | |
All conference fees will be charged a non-refundable 3% credit card processing fee during registration. CANCELLATION POLICY: Any cancellations must be made in writing and sent to iucls@bioascend.com A registrant will receive a return of 50% (minus a processing fee) on refunds requested after March 29, 2022. | ||||
CLAIMING CREDIT
After the conference, create an account or log in and enter the access code to unlock the credit claiming process.
Please Note: Requests to claim MOC Part II credit must be made within one month to report to ABIM. Requests to claim AMA PRA Category 1 Credit™ after three months will be subject to additional fees.